11/25/2023 0 Comments Bridge diagnostics lab![]() Bankruptcy Judge Approves Sale Of Embattled Diagnostic Lab Company.Inside The Scandal: Profit And Greed At An Embattled Laboratory Company.Embattled Lab Nears Settlement With Government Over Kickbacks.Doctor: You're Going To Have A Heart Attack! Patient: Your Tests Results Are Giving Me A Heart Attack!.Way Beyond Kickbacks: More Serious Misconduct Alleged Against Medical Testing Company HDL.Beyond Kickbacks: More Questions About Unnecessary Cardiovascular Biomarker Tests. ![]() "This add on business alone could result in almost a million extra for us." "Thanks to everyone for helping to get this done as soon as possible," she wrote. 'I'd like to have all of the backlog of back testing cleared by the end of July so that the reimbursement will hit us in September when we will need'" the money to pay an anticipated fee. In her email to her colleagues Mallory "separately highlighted the financial side of this 'add on' testing on stored specimens. But at one point HDL CEO Mallory told her colleagues "that a family practice doctor had sent in a prescription to add HDL's expensive CYP2C19 test 'to all of his samples that we have in storage'." She told them that "HDL may have up to 2,500 samples in storage for this doctor." The lawsuit states: "Having the CYP2C19 test run on all samples in storage for this doctor's patients was medically unnecessary, and inducing this doctor to place the order was a violation of the and other healthcare law." There is certainly no indication for the test in patients for whom clopidogrel therapy is not being considered. Under the law, however, the "DOJ could have asserted a claim against HDL for over $1 billion in damages, treble damages, and civil penalties."Ĭardiologists may be interested in one detail in the lawsuit about improper CYP2C19 testing, which has been studied as an indicator of clopidogrel resistance but has never been demonstrated as a beneficial guide to treatment. The lawsuit states that HDL still owes the government $95 million, plus interest, on the DOJ settlement. The lawsuit says Mallory and others "breached their fiduciary duties of loyalty and due care, committed corporate waste, and acted in a grossly negligent and negligent manner" in this matter. HDL, it turns out, provided direct funding for the development of Iggbo, but it was HDL CEO Mallory and others at HDL - not the company itself - who derived financial benefit. The lawsuit also provides some details about HDL's role in the development of Iggbo, the Uber-like phlebotomy service that has been identified as playing a key role in some of the new, post-HDL fraudulent lab schemes. Further, "several consulting agreements provided that HDL would pay additional amounts for writing and speaking engagements." The company paid top doctors $2,500-$3,000 each month in consulting fees, though "the doctors were required to perform only minimal services, such as reviewing HDL marketing materials and participating in MAB meetings and calls." These monthly fees were in addition to the P&H fees already received by the HCPs. ![]() The lawsuit includes new details about HDL's use of a Medical Advisory Board (MAB), speaking fees, and individual consulting agreements as a key part of what Federal investigators charge was an illegal scheme. "HCPs were thereby induced to order medically unnecessary tests for patients." The lawsuit notes that Cornwell "provided HCPs with gifts such as sporting event tickets, gift cards, electronics, and other items to induce HCPs to order tests from HDL, a violation of federal and state anti-kickback laws." The BlueWave sales people told HCPs "that HDL did not intend to collect from patients for co-pay, co-insurance, or deductible amounts" and promoted the process and handling fees the HCPs would receive. The lawsuit names 24 individual BlueWave sales representatives as defendants, including Jeffrey ("Boomer") Cornwell, a top BlueWave salesman and, currently, the vice president of sales at HDL's successor company, True Health Diagnostics.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |